Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)

Summary

The purpose of this study is to assess the efficacy, immunogenicity, and safety of various doses of visilizumab in subjects with intravenous steroid-refractory ulcerative colitis (IVSR-UC) and to evaluate optimal dosing.

Timeline

Start

2006-04

Primary completion

2007-11

Completion

2007-11

Outcome

Outcome not reported

Stopped: “Study Canceled”

Drugs

Indications